## PH: Parker-Hannifin Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -1.1% below STRENGTH zone (3.0-6.0%); PEG 3.40 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($828.47)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Rockport Wealth LLC Invests $2.11 Million in Parker-Hannifin Corporation $PH**
- Source: MarketBeat | 20251207T114542 | Bullish | Relevance: 99%
-  Rockport Wealth LLC recently acquired a new position in Parker-Hannifin Corporation (NYSE:PH), purchasing 3,018 shares valued at approximately $2.11 million during the second quarter. This investment highlights broader institutional interest, with other hedge funds also significantly increasing their stakes in the industrial products company. Parker-Hannifin has shown strong financial performance, beating recent earnings estimates and declaring a quarterly dividend, while analysts maintain a "Moderate Buy" consensus rating for the stock.

**2. Edgestream Partners L.P. Decreases Stock Position in Parker-Hannifin Corporation $PH**
- Source: MarketBeat | 20251208T084954 | Somewhat-Bullish | Relevance: 99%
-  Edgestream Partners L.P. significantly reduced its stake in Parker-Hannifin Corporation by 96.4% in Q2 2025, selling 10,500 shares and retaining 390 shares valued at $272,000. Despite this, other major institutions like Vanguard, Price T. Rowe, JPMorgan, Wellington, and Norges Bank increased their holdings, with institutional investors owning 82.44% of the stock. Parker-Hannifin reported a strong quarterly performance, beat analyst estimates, and maintains a "Moderate Buy" consensus rating with an average price target of $875.65.

**3. Parker-Hannifin Corporation $PH Shares Sold by State Street Corp**
- Source: MarketBeat | 20251209T131153 | Somewhat-Bullish | Relevance: 99%
-  State Street Corp reduced its stake in Parker-Hannifin Corporation by 1.1% in Q2, selling 106,465 shares, and now holds 9,594,879 shares valued at approximately $6.70 billion. The company reported strong Q3 earnings, beating analyst estimates with an EPS of $7.22, and has provided optimistic FY2026 EPS guidance. Parker-Hannifin also declared a quarterly dividend of $1.80, translating to a 0.8% annual yield, and institutional investors own a significant 82.44% of the stock.

**4. Parker-Hannifin Corporation $PH Stock Holdings Boosted by Axa S.A.**
- Source: MarketBeat | 20251209T083445 | Somewhat-Bullish | Relevance: 98%
-  Axa S.A. significantly increased its stake in Parker-Hannifin Corporation, boosting its holdings by 61.1% in the second quarter. Other institutional investors also modified their positions, while analysts have largely issued "Buy" ratings with a consensus target price of $883.41. The article also details recent insider stock sales and the company's financial performance.

**5. Citigroup Adjusts Price Target on Parker-Hannifin to $1,006 From $960, Maintains Buy Rating**
- Source: marketscreener.com | 20251208T120840 | Somewhat-Bullish | Relevance: 97%
-  Citigroup has increased its price target on Parker-Hannifin (NYSE: PH) from $960 to $1,006, while maintaining a "Buy" rating on the stock. This adjustment reflects an updated outlook on the industrial machinery and equipment company. The article also provides recent news headlines related to Parker-Hannifin's stock performance and acquisition activities.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Citigroup | $1006 | $960 | +5% |
| 2025-12-04 | Barclays | $950 | $906 | +5% |
| 2025-11-12 | Baird | $960 | $930 | +3% |
| 2025-11-12 | Susquehanna | $1000 | $960 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Citigroup | main | Buy |
| 2025-12-04 | Barclays | main | Overweight |
| 2025-11-12 | Baird | main | Outperform |
| 2025-11-12 | Susquehanna | main | Positive |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 4 ($2.29M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (-0.1%)
- Blackrock Inc.: 7.8% (+0.6%)
- State Street Corpora: 7.6% (-0.7%)
- Procyon Advisors, LL: 4.0% (+158565.8%)
- Bank of America Corp: 3.1% (+0.6%)

### Key Risks

1. Valuation stretched: PEG 3.4x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 4 raises (avg +4%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 3.40 signals overvaluation risk, limited margin of safety. Forward P/E 26.1x stretched relative to 9% growth. Quality metrics strong (ROE 27%, margin 18%). Insider selling cluster ($2.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $109.2B |
| Beta | 1.25 |
| 52W Range | $488.45 - $888.82 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.40 |
| Forward P/E | 26.1 |
| Current P/E | 28.5 |
| YoY Growth | 9.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.3% to -1.1% (-1.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.1pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.07% (CS: 48) | Neutral |
| RSI_14 | 62.3 | Neutral |
| MACD Histogram | -0.14 | Bearish |
| vs SMA20 | 1.015x | Above |
| vs SMA50 | 1.082x | Above |
| vs SMA200 | 1.222x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $862.93
- **Stop Loss:** $828.47 (4.0% risk)
- **Target:** $897.39 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 14
- **Position Value:** $12,081.02
- **Portfolio %:** 12.08%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-29 (Est: $7.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.62 | $7.22 | +9.0% |
| 2025Q2 | $7.08 | $7.69 | +8.6% |
| 2025Q1 | $6.72 | $6.94 | +3.3% |
| 2024Q4 | $6.23 | $6.53 | +4.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*